Meanwhile, flow cytometric analysis found that an anti-PGRMC1 antibody recognizing the N-terminal domain (residues 1–46) of PGRMC1 was not able to bind to csPGRMC1 on cancer cells, although it was able to recognize intracellular PGRMC1 in saponin-treated cells. Here, PGRMC1 is linked to cancer.